COVID-19

Article Round Up: How the COVID-19 Outbreak is Impacting the Pharmaceutical Industry When Launching a New Drug

2020-10-14T18:57:40+00:00October 14th, 2020|Categories: Blog, COVID-19|

The COVID-19 pandemic is unprecedented and unpredictable. Nevertheless, we are remaining flexible as we continue to support pharmaceutical manufacturers and their life-changing work. Regardless of which stage you’re at in the drug development journey — from clinical trials to loss of exclusivity — we’re trusted pharma consultants who have the insight, expertise, and solutions needed to keep you moving. Since March, our team of experts have tracked the pandemic’s impact [...]

Comments Off on Article Round Up: How the COVID-19 Outbreak is Impacting the Pharmaceutical Industry When Launching a New Drug

COVID-19 Q&A: How will the outbreak impact DSCSA

2020-06-03T14:26:01+00:00June 3rd, 2020|Categories: COVID-19|Tags: |

COVID-19 is impacting the healthcare system in a way we’ve never seen before, and pharmaceutical manufacturers are facing new challenges at rapid speeds. To help keep you informed, we’re releasing a special Q&A series with our experts to discuss the virus’s impact on each stage of the launch journey. Today, we spoke with DSCSA and Serialization Services Manager Michael Rowe about the effect of COVID-19 [...]

Comments Off on COVID-19 Q&A: How will the outbreak impact DSCSA

COVID-19 Q&A: How will the outbreak impact U.S. pharmaceutical marketing and promotions

2020-05-19T15:03:20+00:00May 19th, 2020|Categories: COVID-19|Tags: |

COVID-19 is impacting the healthcare system in a way we’ve never seen before, and pharmaceutical manufacturers are facing new challenges at rapid speeds. To help keep you informed, we’re releasing a special Q&A series with our experts to discuss the virus’s impact on each stage of the development journey. Today, we spoke with David Ward, Vice President for EHRx Solutions, Sara Stricker, Manager at CEEK [...]

Comments Off on COVID-19 Q&A: How will the outbreak impact U.S. pharmaceutical marketing and promotions

COVID-19 Q&A: How will the outbreak impact small companies

2020-05-18T14:14:46+00:00May 15th, 2020|Categories: COVID-19|Tags: |

Timing Funding PUBLIC FUNDING If a manufacturer has received public funding, they are feeling the effects of the stock market downturn and may need to find ways to decrease budget and/or bring about additional funding sources. PRIVATELY FUNDED If a manufacturer has received funding from private investors, there may be more inherent cash security, but they must [...]

Comments Off on COVID-19 Q&A: How will the outbreak impact small companies

Covid-19 Q&A: How COVID-19 Is impacting State Licensing

2020-06-17T14:58:25+00:00April 28th, 2020|Categories: COVID-19|Tags: |

COVID-19 is impacting the healthcare system in a way we’ve never seen before, and pharmaceutical manufacturers are facing new challenges at rapid speeds. To help keep you informed, we’re releasing a special Q&A series with our experts to discuss the virus’s impact on each stage of the launch journey. Today, we spoke with Vice President of PharmaLicense Ryan Fields about the effect of COVID-19 on state licensing. [...]

Comments Off on Covid-19 Q&A: How COVID-19 Is impacting State Licensing

Covid-19 Q&A: How Will COVID-19 Impact 3PL Inspections?

2020-04-28T13:57:21+00:00April 22nd, 2020|Categories: COVID-19|Tags: |

COVID-19 is impacting the healthcare system in a way we’ve never seen before, and pharmaceutical manufacturers are facing new challenges at rapid speeds. To help keep you informed, we’re releasing a special Q&A series with our experts to discuss the virus’s impact on each stage of the launch journey. If you’d like to speak with us about how to plan your 3PL inspection process, get in touch. [...]

Comments Off on Covid-19 Q&A: How Will COVID-19 Impact 3PL Inspections?

Virtual Payer Panels and Advisory Boards

2020-04-24T23:04:53+00:00April 15th, 2020|Categories: COVID-19|

Virtual Payer Panels and Advisory Boards As the global landscape continues to change with daily COVID-19 developments, it’s vital that manufacturers remain adaptable. Which is why Two Labs is offering innovative ways of doing competitive simulations and seminars, virtual payer panels, and interactive client meetings. Our Market Access team is here to arrange virtual panel discussions, giving your team the chance to discuss challenges and opportunities your [...]

Comments Off on Virtual Payer Panels and Advisory Boards

COVID-19 Q&A: Is Your Clinical Trial On Hold?

2022-05-24T14:04:08+00:00April 14th, 2020|Categories: COVID-19|Tags: |

COVID-19 is impacting the healthcare system in a way we’ve never seen before, and pharmaceutical manufacturers are facing new challenges at rapid speeds. To help keep you informed, we’re releasing a special Q&A series with our experts to discuss the virus’s impact on each stage of the development journey. Let's Talk Posted by: Will Pih EVP of Specialty Commercialization [...]

Comments Off on COVID-19 Q&A: Is Your Clinical Trial On Hold?

COVID-19 Vaccine Update

2020-05-18T20:09:04+00:00April 3rd, 2020|Categories: COVID-19|Tags: |

Our team took a look at the most recent pharmaceutical developments from the week, including where we are with treatment options and how manufacturers are racing to find an effective treatment for COVID-19. COVID-19 has had significant effects across the healthcare system There are several vaccines and drug candidates in development which could help prevent or treat COVID-19 VACCINES* [fusion_table [...]

Comments Off on COVID-19 Vaccine Update

A message regarding COVID-19 and Ongoing work

2020-04-06T23:24:56+00:00March 28th, 2020|Categories: COVID-19|Tags: |

A message regarding COVID-19 and Ongoing work To Our Community, Like many of you, we’ve had to be flexible and responsive during the past couple of weeks and plan to continue doing so as the COVID-19 pandemic unfolds in the weeks and months ahead. We’re currently working remotely to keep our employees, colleagues, and families safe. Being that we already have a large remote team, the transition [...]

Comments Off on A message regarding COVID-19 and Ongoing work
Go to Top